- Category : Healthcare
- Region : APAC
- Publishing Date : 06/30/2022
Asia Pacific Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity
Asia Pacific nutrigenomics market will grow by 16.9% annually with a total addressable market cap of $4,313.0 million over 2022-2031, driven by the advancements in nutritional & medical technology, the increasing rate of obesity and lifestyle-related diseases, increasing awareness about the relationship between nutrition/gene/health, personalized diet and genetic nutrition profile, and the increasing family disposable incomes.
Highlighted with 32 tables and 58 figures, this 121-page report “Asia Pacific Nutrigenomics Market 2021-2031 by Offering (Products, Testing Services), Test Technology, Test Sample (Buccal Swab, Saliva, Blood, Others), Application (Women’s Health, Metabolic Disorders, Immune Health, Cancer, Cardiovascular, Diabetes), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific nutrigenomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific nutrigenomics market in every aspect of the classification from perspectives of Offering, Test Technology, Test Sample, Application, End User, and Country.
Based on Offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Products
o Probiotics
o Prebiotics
o Vitamins & Supplements
• Testing Services
o Nutrigenomics Clinical Testing
o Nutrigenomics Research Testing
Based on Test Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Next-generation Sequencing
• Real-time PCR
• DNA Microarray
• Sanger Sequencing
By Test Sample, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Buccal Swab Sample
• Saliva Sample
• Blood Sample
• Other Samples
By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Women’s Health
• Metabolic Disorders
• Immune Health
• Cancer Research
• Cardiovascular Diseases
• Diabetes
• Other Applications
By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals
• Nutrition Clinics
• Diagnostics Laboratories
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Offering，Application and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
BASF SE
BioGaia
Cell Logic
Cura Integrative Medicine
DNAfit
DuPont de Nemours, Inc.
Garden of Life, LLC
GeneOmbio
Genova Diagnostics, Inc.
GX Sciences, Inc.
Ingredion Incorporated
Jarrow Formulas Inc.
Koninklijke DSM N.V.
MedGenome
Metagenics, Inc.
Nutrigenomix Inc.
Unilever Group
XCODE Life
Yakult Honsha Co., Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
List of Tables:
Table 1. Snapshot of Asia Pacific Nutrigenomics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 33
Table 5. Main Product Trends and Market Opportunities in Asia Pacific Nutrigenomics Market 37
Table 6. Asia Pacific Nutrigenomics Market by Offering, 2021-2031, $ mn 45
Table 7. Asia Pacific Nutrigenomics Market: Products by Type, 2021-2031, $ mn 47
Table 8. Asia Pacific Nutrigenomics Market: Testing Services by Type, 2021-2031, $ mn 51
Table 9. Asia Pacific Nutrigenomics Market by Test Technology, 2021-2031, $ mn 54
Table 10. Asia Pacific Nutrigenomics Market by Test Sample, 2021-2031, $ mn 60
Table 11. Asia Pacific Nutrigenomics Market by Application, 2021-2031, $ mn 66
Table 12. Asia Pacific Nutrigenomics Market by End User, 2021-2031, $ mn 75
Table 13. APAC Nutrigenomics Market by Country, 2021-2031, $ mn 82
Table 14. Japan Nutrigenomics Market by Offering, 2021-2031, $ mn 86
Table 15. Japan Nutrigenomics Market by Application, 2021-2031, $ mn 86
Table 16. Japan Nutrigenomics Market by End User, 2021-2031, $ mn 86
Table 17. China Nutrigenomics Market by Offering, 2021-2031, $ mn 88
Table 18. China Nutrigenomics Market by Application, 2021-2031, $ mn 88
Table 19. China Nutrigenomics Market by End User, 2021-2031, $ mn 88
Table 20. Australia Nutrigenomics Market by Offering, 2021-2031, $ mn 90
Table 21. Australia Nutrigenomics Market by Application, 2021-2031, $ mn 90
Table 22. Australia Nutrigenomics Market by End User, 2021-2031, $ mn 90
Table 23. India Nutrigenomics Market by Offering, 2021-2031, $ mn 92
Table 24. India Nutrigenomics Market by Application, 2021-2031, $ mn 92
Table 25. India Nutrigenomics Market by End User, 2021-2031, $ mn 92
Table 26. South Korea Nutrigenomics Market by Offering, 2021-2031, $ mn 94
Table 27. South Korea Nutrigenomics Market by Application, 2021-2031, $ mn 94
Table 28. South Korea Nutrigenomics Market by End User, 2021-2031, $ mn 94
Table 29. Nutrigenomics Market in Rest of APAC by Country/Region, 2021-2031, $ mn 96
Table 30. BASF SE: Company Snapshot 101
Table 31. BASF SE: Business Segmentation 102
Table 32. BASF SE: Product Portfolio 102
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 34
2.4 Emerging Opportunities and Market Trends 37
2.5 Porter’s Fiver Forces Analysis 41
3 Segmentation of Asia Pacific Market by Offering 45
3.1 Market Overview by Offering 45
3.2 Products 47
3.3.1 Probiotics 48
3.3.2 Prebiotics 49
3.3.3 Vitamins & Supplements 50
3.3 Testing Services 51
3.3.1 Nutrigenomics Clinical Testing 52
3.3.2 Nutrigenomics Research Testing 53
4 Segmentation of Asia Pacific Market by Test Technology 54
4.1 Market Overview by Test Technology 54
4.2 Next-generation Sequencing 56
4.3 Real-time PCR 57
4.4 DNA Microarray 58
4.5 Sanger Sequencing 59
5 Segmentation of Asia Pacific Market by Test Sample 60
5.1 Market Overview by Test Sample 60
5.2 Buccal Swab Sample 62
5.3 Saliva Sample 63
5.4 Blood Sample 64
5.5 Other Samples 65
6 Segmentation of Asia Pacific Market by Application 66
6.1 Market Overview by Application 66
6.2 Women’s Health 68
6.3 Metabolic Disorders 69
6.4 Immune Health 70
6.5 Cancer Research 71
6.6 Cardiovascular Diseases 72
6.7 Diabetes 73
6.8 Other Applications 74
7 Segmentation of Asia Pacific Market by End User 75
7.1 Market Overview by End User 75
7.2 Hospitals 77
7.3 Nutrition Clinics 78
7.4 Diagnostics Laboratories 79
7.5 Other End Users 80
8 Asia-Pacific Market 2021-2031 by Country 81
8.1 Overview of Asia-Pacific Market 81
8.2 Japan 84
8.3 China 87
8.4 Australia 89
8.5 India 91
8.6 South Korea 93
8.7 Rest of APAC Region 95
9 Competitive Landscape 97
9.1 Overview of Key Vendors 97
9.2 New Product Launch, Partnership, Investment, and M&A 100
9.3 Company Profiles 101
BASF SE 101
BioGaia 103
Cell Logic 104
Cura Integrative Medicine 105
DNAfit 106
DuPont de Nemours, Inc. 107
Garden of Life, LLC 108
GeneOmbio 109
Genova Diagnostics, Inc. 110
GX Sciences, Inc. 111
Ingredion Incorporated 112
Jarrow Formulas Inc. 113
Koninklijke DSM N.V. 114
MedGenome 115
Metagenics, Inc. 116
Nutrigenomix Inc. 117
Unilever Group 118
XCODE Life 119
Yakult Honsha Co., Ltd. 120
RELATED REPORTS 121